Direct and indirect effects of central and general adiposity on cardiovascular diseases

The Tehran Lipid and Glucose Study

Mahmood Bakhtiyari, Nicole M Schmidt, Farzad Hadaegh, Davood Khalili, Nasrin Mansournia, Samaneh Asgari, Mohammad A. Mansournia

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: The mechanisms linking body mass index to cardiovascular disease are still not clearly defined. The purpose of this study was to find out how much of the effect of central and general adiposity on cardiovascular disease is mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods and results: The study population included participants, aged ≥30 years, free of cardiovascular disease at baseline with median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using the inverse odds weighting method in the context of survival models. Systolic blood pressure, total serum cholesterol, and fasting plasma glucose as the primary measure of blood glucose were used as mediators. Blood pressure and cholesterol with indirect hazard ratios of 1.09 (95% confidence interval: 1.006–1.18) and 1.35 (95% confidence interval: 1.12–1.62) were the most important mediators for overweight-cardiovascular disease and obesity-cardiovascular disease relationships, respectively. The proportion mediated of overweight was 22% (6–47%) for blood pressure, 18% (5–37%) for blood glucose, and 20% (7–43%) for cholesterol. The same measure for obesity was 65% (35–91%) for cholesterol. For central adiposity, blood pressure, glucose, and cholesterol were the most important mediators with proportion mediated of 36% (17–72%), 23% (9–48%), and 21% (8–45%), respectively. Conclusions: The findings of this study show that proper control of cardiometabolic risk factors of blood pressure, blood glucose, and dyslipidemia in an adult population can be effective to significantly reduce the effects of general and abdominal adiposity on cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)1170-1181
Number of pages12
JournalEuropean Journal of Preventive Cardiology
Volume25
Issue number11
DOIs
StatePublished - Jul 1 2018

Fingerprint

Adiposity
Cardiovascular Diseases
Blood Pressure
Lipids
Glucose
Cholesterol
Blood Glucose
Obesity
Confidence Intervals
Dyslipidemias
Population
Fasting
Body Mass Index
Serum

Keywords

  • Cardiovascular disease
  • direct and indirect effects
  • inverse odds weighting
  • mediator effects

PubMed: MeSH publication types

  • Journal Article

Cite this

Direct and indirect effects of central and general adiposity on cardiovascular diseases : The Tehran Lipid and Glucose Study. / Bakhtiyari, Mahmood; Schmidt, Nicole M; Hadaegh, Farzad; Khalili, Davood; Mansournia, Nasrin; Asgari, Samaneh; Mansournia, Mohammad A.

In: European Journal of Preventive Cardiology, Vol. 25, No. 11, 01.07.2018, p. 1170-1181.

Research output: Contribution to journalArticle

Bakhtiyari, Mahmood ; Schmidt, Nicole M ; Hadaegh, Farzad ; Khalili, Davood ; Mansournia, Nasrin ; Asgari, Samaneh ; Mansournia, Mohammad A. / Direct and indirect effects of central and general adiposity on cardiovascular diseases : The Tehran Lipid and Glucose Study. In: European Journal of Preventive Cardiology. 2018 ; Vol. 25, No. 11. pp. 1170-1181.
@article{4d6054aeff5446bc900a54b1269f943c,
title = "Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study",
abstract = "Aim: The mechanisms linking body mass index to cardiovascular disease are still not clearly defined. The purpose of this study was to find out how much of the effect of central and general adiposity on cardiovascular disease is mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods and results: The study population included participants, aged ≥30 years, free of cardiovascular disease at baseline with median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using the inverse odds weighting method in the context of survival models. Systolic blood pressure, total serum cholesterol, and fasting plasma glucose as the primary measure of blood glucose were used as mediators. Blood pressure and cholesterol with indirect hazard ratios of 1.09 (95{\%} confidence interval: 1.006–1.18) and 1.35 (95{\%} confidence interval: 1.12–1.62) were the most important mediators for overweight-cardiovascular disease and obesity-cardiovascular disease relationships, respectively. The proportion mediated of overweight was 22{\%} (6–47{\%}) for blood pressure, 18{\%} (5–37{\%}) for blood glucose, and 20{\%} (7–43{\%}) for cholesterol. The same measure for obesity was 65{\%} (35–91{\%}) for cholesterol. For central adiposity, blood pressure, glucose, and cholesterol were the most important mediators with proportion mediated of 36{\%} (17–72{\%}), 23{\%} (9–48{\%}), and 21{\%} (8–45{\%}), respectively. Conclusions: The findings of this study show that proper control of cardiometabolic risk factors of blood pressure, blood glucose, and dyslipidemia in an adult population can be effective to significantly reduce the effects of general and abdominal adiposity on cardiovascular diseases.",
keywords = "Cardiovascular disease, direct and indirect effects, inverse odds weighting, mediator effects",
author = "Mahmood Bakhtiyari and Schmidt, {Nicole M} and Farzad Hadaegh and Davood Khalili and Nasrin Mansournia and Samaneh Asgari and Mansournia, {Mohammad A.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1177/2047487318780030",
language = "English (US)",
volume = "25",
pages = "1170--1181",
journal = "European Journal of Preventive Cardiology",
issn = "2047-4873",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Direct and indirect effects of central and general adiposity on cardiovascular diseases

T2 - The Tehran Lipid and Glucose Study

AU - Bakhtiyari, Mahmood

AU - Schmidt, Nicole M

AU - Hadaegh, Farzad

AU - Khalili, Davood

AU - Mansournia, Nasrin

AU - Asgari, Samaneh

AU - Mansournia, Mohammad A.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Aim: The mechanisms linking body mass index to cardiovascular disease are still not clearly defined. The purpose of this study was to find out how much of the effect of central and general adiposity on cardiovascular disease is mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods and results: The study population included participants, aged ≥30 years, free of cardiovascular disease at baseline with median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using the inverse odds weighting method in the context of survival models. Systolic blood pressure, total serum cholesterol, and fasting plasma glucose as the primary measure of blood glucose were used as mediators. Blood pressure and cholesterol with indirect hazard ratios of 1.09 (95% confidence interval: 1.006–1.18) and 1.35 (95% confidence interval: 1.12–1.62) were the most important mediators for overweight-cardiovascular disease and obesity-cardiovascular disease relationships, respectively. The proportion mediated of overweight was 22% (6–47%) for blood pressure, 18% (5–37%) for blood glucose, and 20% (7–43%) for cholesterol. The same measure for obesity was 65% (35–91%) for cholesterol. For central adiposity, blood pressure, glucose, and cholesterol were the most important mediators with proportion mediated of 36% (17–72%), 23% (9–48%), and 21% (8–45%), respectively. Conclusions: The findings of this study show that proper control of cardiometabolic risk factors of blood pressure, blood glucose, and dyslipidemia in an adult population can be effective to significantly reduce the effects of general and abdominal adiposity on cardiovascular diseases.

AB - Aim: The mechanisms linking body mass index to cardiovascular disease are still not clearly defined. The purpose of this study was to find out how much of the effect of central and general adiposity on cardiovascular disease is mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods and results: The study population included participants, aged ≥30 years, free of cardiovascular disease at baseline with median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using the inverse odds weighting method in the context of survival models. Systolic blood pressure, total serum cholesterol, and fasting plasma glucose as the primary measure of blood glucose were used as mediators. Blood pressure and cholesterol with indirect hazard ratios of 1.09 (95% confidence interval: 1.006–1.18) and 1.35 (95% confidence interval: 1.12–1.62) were the most important mediators for overweight-cardiovascular disease and obesity-cardiovascular disease relationships, respectively. The proportion mediated of overweight was 22% (6–47%) for blood pressure, 18% (5–37%) for blood glucose, and 20% (7–43%) for cholesterol. The same measure for obesity was 65% (35–91%) for cholesterol. For central adiposity, blood pressure, glucose, and cholesterol were the most important mediators with proportion mediated of 36% (17–72%), 23% (9–48%), and 21% (8–45%), respectively. Conclusions: The findings of this study show that proper control of cardiometabolic risk factors of blood pressure, blood glucose, and dyslipidemia in an adult population can be effective to significantly reduce the effects of general and abdominal adiposity on cardiovascular diseases.

KW - Cardiovascular disease

KW - direct and indirect effects

KW - inverse odds weighting

KW - mediator effects

UR - http://www.scopus.com/inward/record.url?scp=85047949764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047949764&partnerID=8YFLogxK

U2 - 10.1177/2047487318780030

DO - 10.1177/2047487318780030

M3 - Article

VL - 25

SP - 1170

EP - 1181

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4873

IS - 11

ER -